EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Comparison of estradiol hemihydrate 10 µg vaginal tablets versus estradiol hemihydrate 10 µg vaginal gel in postmenopausal women with vaginal atrophy: a randomized crossover study

Kanchanok Taemamu, Prasong Tanmahasamut, Manee Rattanachaiyanont, Thanyarat Wongwananuruk, Panicha Chantrapanichkul, Chatchai Areeswate

Archives of Gynecology and Obstetrics · 2025

DOI: 10.1007/s00404-025-08171-8 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Archives of Gynecology and Obstetrics, 2025. Verfasst von Kanchanok Taemamu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thail…. Hauptthemen laut MEDLINE: Postmenopause, Estradiol, Vagina, Vaginal Diseases. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mahidol University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This randomized crossover study evaluated the 12 week efficacy of a 10 µg estradiol hemihydrate vaginal tablet versus a vaginal gel (available at Siriraj Hospital, Thailand) in postmenopausal women with vaginal atrophy. Secondary endpoints included the most bothersome symptom, vaginal health index (VHI), vaginal pH, female sexual function index, serum estradiol, endometrial thickness, ease of use, comfort, and satisfaction.

Methods

Ninety participants were randomized to receive either the 10 µg estradiol tablet or the gel daily for 2 weeks, followed by twice-weekly application for 10 weeks. Afterward, they switched to the alternate treatment for another 12 weeks using the same dosing regimen. Assessments of VHI, pH, vaginal maturation value (VMV), female sexual function index, endometrial thickness, and estradiol levels were conducted at baseline, 12 weeks, and 24 weeks.

Results

Eighty-five participants completed the study. At 12 weeks (intention-to-treat analysis), the gel significantly increased VMV compared with the tablet (60.16 ± 12.00 vs 51.62 ± 23.77; P = 0.035; 95% CI 0.54 to 16.46), although the 95% CI included the noninferiority margin of 15. Per-protocol analysis showed no significant difference between groups. VHI improved, and pH decreased more markedly with the gel at 12 weeks. By 24 weeks, there were no significant between-group differences in VMV, pH, or most bothersome symptom. Acceptability was high for both treatments, although 55.3% of participants indicated a preference for continued gel use.

Conclusions

Noninferiority of the 10 µg estradiol hemihydrate tablet relative to the gel could not be established. However, both treatments exhibited clinical benefits and high patient satisfaction, providing valuable insights for therapeutic decision-making in postmenopausal vaginal atrophy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PostmenopauseEstradiolVaginaVaginal DiseasesEstrogensHumansFemaleCross-Over StudiesVaginal Creams, Foams, and JelliesMiddle AgedAtrophyAdministration, IntravaginalAgedPatient SatisfactionTabletsTreatment Outcome

Stichwörter der Autor:innen

Estrogen replacement therapyMenopauseVaginal atrophyVaginal gelVaginal tablet

Substanzen

EstradiolVaginal Creams, Foams, and JelliesEstrogensTablets

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand.
  • Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand. prasong.tan@mahidol.ac.th.

Förderung

  • Mahidol University

Zitieren

APA

Taemamu, K., Tanmahasamut, P., Rattanachaiyanont, M., Wongwananuruk, T., Chantrapanichkul, P., & Areeswate, C. (2025). Comparison of estradiol hemihydrate 10 µg vaginal tablets versus estradiol hemihydrate 10 µg vaginal gel in postmenopausal women with vaginal atrophy: a randomized crossover study. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-025-08171-8

Vancouver

Taemamu K, Tanmahasamut P, Rattanachaiyanont M, Wongwananuruk T, Chantrapanichkul P, Areeswate C. Comparison of estradiol hemihydrate 10 µg vaginal tablets versus estradiol hemihydrate 10 µg vaginal gel in postmenopausal women with vaginal atrophy: a randomized crossover study. Archives of Gynecology and Obstetrics. 2025. doi:10.1007/s00404-025-08171-8

BibTeX
@article{Taemamu2025,
  author = {Taemamu, Kanchanok and Tanmahasamut, Prasong and Rattanachaiyanont, Manee and Wongwananuruk, Thanyarat and Chantrapanichkul, Panicha and Areeswate, Chatchai},
  title = {Comparison of estradiol hemihydrate 10 µg vaginal tablets versus estradiol hemihydrate 10 µg vaginal gel in postmenopausal women with vaginal atrophy: a randomized crossover study},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2025},
  doi = {10.1007/s00404-025-08171-8}
}
Kostenlos starten →